1ABBV:BIT
AbbVie Common Stock
€231.80
arrow_downward
-0.81%(-1.90) 1D
Sep 28, 3:08:19 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1ABBV...
Mkt. cap
470.55B
Avg. vol.
35.00
Volume
0.00
52-wk high
€234.90
52-wk low
€168.00
No. of employees
57K
Mkt. cap
470.55B
Avg. vol.
35.00
Volume
0.00
52-wk high
€234.90
52-wk low
€168.00
No. of employees
57K
News stories
From web sources and news partners
Yahoo Finance
·
4 hours ago
Is AbbVie (ABBV) A Bargain After FDA Approval Of JUVMO For Parkinson's?
AD HOC NEWS
·
12 hours ago
AbbVie stock last traded at USD 266.40 on September 28, 2026
Investing.com
·
14 hours ago
AbbVie gets FDA approval for Parkinson’s disease drug Juvmo
Traders Union
·
18 hours ago
AbbVie shares weekly forecast: recovery holds but faces a stretched setup
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com